Patients with CKD have decreased renal expression of PPARα [28] and frequently suffer from various systemic disorders, including dyslipidemia, hypoglycemia, malnutrition, frailty, and sarcopenia [45, 46, 47, 48]. The gene discussed is PPARA; the disease is metabolic syndrome.